Session Details

F092 Think Like an Expert about Ichthyosis

Mon, Mar 22, 3:30 PM - 5:30 PM
2 CME Available Forum

DESCRIPTION

This session will be a lively, highly interactive discussion of challenging ichthyosis/epidermal differentiation disorder (EDD) patient cases and updates and controversies in the field. Audience members will have a unique opportunity to observe how complex cases are approached by experts in their daily practice, as well as interact with and ask questions of these experts. A patient advocate will be present to provide the patient perspective.

LEARNING OBJECTIVES

1.

Develop an approach to managing patients with unfamiliar, uncommon, and complex skin disease.

2.

Order appropriate genetic testing for patients with ichthyoses/epidermal differentiation disorders and other inherited skin conditions.

3.

Locate educational and support resources for patients affected by ichthyosis and their families

DIRECTOR

Cheryl Marie Bayart, MD, FAAD

Cheryl Marie Bayart, MD, FAAD

SPEAKERS

Lihi Atzmony, MD, IFAAD

Lihi Atzmony, MD, IFAAD

Denise Gass

Denise Gass

Antoni Gostynski, MD, PhD, MSc, IFAAD

Antoni Gostynski, MD, PhD, MSc, IFAAD

Juliette Mazereeuw-Hautier

Juliette Mazereeuw-Hautier

Ryland Mortlock

Ryland Mortlock

Amy S. Paller, MD, FAAD

Amy S. Paller, MD, FAAD

Northwestern University

Janice Schwartz

Janice Schwartz

PC Project (Pachyonychia Congenita Project

DISCLOSURES

Lihi Atzmony, MD, IFAAD

No financial relationships exist with ineligible companies.

Cheryl Marie Bayart, MD, FAAD

Abeona Therapeutics – Advisory Board(Honoraria);

Denise Gass

No financial relationships exist with ineligible companies.

Antoni Gostynski, MD, PhD, MSc, IFAAD

AbbVie – Advisory Board(Honoraria); Almirall – Advisory Board(Honoraria); Boehringer Ingelheim – Advisory Board(Honoraria); La Roche-Posay – Other(Grants/Research Funding); Leo Foundation – Other(Grants/Research Funding); Leo Pharma – Advisory Board(Honoraria); Novo Nordisk A/S – Stockholder Public Company(Stock); Pfizer – Stockholder Public Company(Stock); Pfizer Inc. – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria); UCB – Advisory Board(Honoraria), Stockholder Public Company(Stock);

Juliette Mazereeuw-Hautier

No financial relationships exist with ineligible companies.

Amy S. Paller, MD, FAAD

AbbVie – Data Safety Monitoring Board(Honoraria), Investigator(Grants/Research Funding); Abeona Therapeutics – Data Safety Monitoring Board(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Honoraria); BioCryst Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria), Data Safety Monitoring Board(Honoraria); BioMendics, LLC – Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Honoraria); Castle Creek Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Chiesi Farmaceutici – Consultant (1099 relationship)(Honoraria); Daiichi Sankyo – Data Safety Monitoring Board(Honoraria); Dermavant Sciences, Inc. – Investigator(Grants/Research Funding); Eli Lilly – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Galderma – Data Safety Monitoring Board(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); Johnson & Johnson Innovative Medicine – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Krystal Biotech, Inc – Consultant(Honoraria); L'Oréal France – Consultant (1099 relationship)(Honoraria); Leo Pharma Inc – Consultant(Honoraria); MoonLake Immunotherapeutics – Consultant (1099 relationship)(Honoraria); Pelthos Therapeutics – Consultant (1099 relationship)(Honoraria); Quoin Pharmaceuticals Ltd – Consultant (1099 relationship)(Honoraria); Regeneron – Consultant(Honoraria), Investigator(Grants/Research Funding); Sanofi Genzyme – Consultant(Honoraria); UCB – Investigator(Grants/Research Funding);

Janice Schwartz

No financial relationships exist with ineligible companies.